Panax notoginseng saponins promotes angiogenesis after cerebral ischemia-reperfusion injury
Open Access
- 26 August 2024
- journal article
- research article
- Published by Elsevier in Journal of Ginseng Research
- Vol. 48 (6) , 592-602
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Meteorological Sciences (2021-I2M-1-031)
- Yunnan Provincial Science and Technology Department (202102AA310048)
This publication has 53 references indexed in Scilit:
- Ischemic StrokeThe American Journal of Medicine, 2021
- Notoginsenoside R1 activates the NAMPT-NAD+-SIRT1 cascade to promote postischemic angiogenesis by modulating Notch signalingBiomedicine & Pharmacotherapy, 2021
- Traditional Chinese medicine formulas, extracts, and compounds promote angiogenesisBiomedicine & Pharmacotherapy, 2020
- Xueshuantong Injection (Lyophilized) Attenuates Cerebral Ischemia/Reperfusion Injury by the Activation of Nrf2–VEGF PathwayNeurochemical Research, 2018
- Panax notoginseng saponins administration modulates pro- /anti-inflammatory factor expression and improves neurologic outcome following permanent MCAO in ratsMetabolic Brain Disease, 2016
- MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2Biochemical Pharmacology, 2013
- Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathwaysBiochemical Pharmacology, 2012
- Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesisAngiogenesis, 2011
- Angiogenesis after cerebral ischemiaActa Neuropathologica, 2009
- Angiogenesis in Health and Disease: Insights into Basic Mechanisms and Therapeutic OpportunitiesJournal of Dental Education, 2002